G

GH Research PLC
NASDAQ:GHRS

Watchlist Manager
GH Research PLC
NASDAQ:GHRS
Watchlist
Price: 8.75 USD -5.3% Market Closed
Market Cap: 455.3m USD
Have any thoughts about
GH Research PLC?
Write Note

GH Research PLC
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GH Research PLC
Accrued Liabilities Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
COPN
OVB

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
GH Research PLC
NASDAQ:GHRS
Accrued Liabilities
$2.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Accrued Liabilities
$533.1m
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
0%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Accrued Liabilities
$858m
CAGR 3-Years
14%
CAGR 5-Years
29%
CAGR 10-Years
18%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Accrued Liabilities
$34.6m
CAGR 3-Years
52%
CAGR 5-Years
27%
CAGR 10-Years
21%
Cosmo Pharmaceuticals NV
SIX:COPN
Accrued Liabilities
€5.3m
CAGR 3-Years
74%
CAGR 5-Years
49%
CAGR 10-Years
33%
Ovoca Bio PLC
LSE:OVB
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is GH Research PLC's Accrued Liabilities?
Accrued Liabilities
2.3m USD

Based on the financial report for Dec 31, 2023, GH Research PLC's Accrued Liabilities amounts to 2.3m USD.

What is GH Research PLC's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 1Y
-3%

Over the last year, the Accrued Liabilities growth was -3%.

Back to Top